Cannabis Global (Cannabis Global) Inventory-to-Revenue : 0.25 (As of May. 2022)

View and export this data going back to 2008. Start your Free Trial

What is Cannabis Global Inventory-to-Revenue?

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Cannabis Global's Average Total Inventories for the quarter that ended in May. 2022 was $0.20 Mil. Cannabis Global's Revenue for the three months ended in May. 2022 was $0.79 Mil. Cannabis Global's Inventory-to-Revenue for the quarter that ended in May. 2022 was 0.25.

Cannabis Global's Inventory-to-Revenue for the quarter that ended in May. 2022 declined from Feb. 2022 (0.42) to Feb. 2022 (0.25)

A decrease in the Inventory-to-Revenue from one quarter to next indicates that one of these is occurring:

1. investment in inventory is shrinking in relation to revenue
2. revenue are increasing
No matter which situation is causing the reduction in the Inventory-to-Revenue, either one suggests that business's inventory levels and its cash flow are effectively managed.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Cannabis Global's Days Inventory for the three months ended in May. 2022 was 23.05.

Inventory Turnover measures how fast the company turns over its inventory within a year. Cannabis Global's Inventory Turnover for the quarter that ended in May. 2022 was 3.96.

Cannabis Global Inventory-to-Revenue Historical Data

The historical data trend for Cannabis Global's Inventory-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cannabis Global Inventory-to-Revenue Chart

Cannabis Global Annual Data

Trend

Aug12

Aug13

Aug14

Aug15

Aug16

Aug17

Aug18

Aug19

Aug20

Aug21

Inventory-to-Revenue

Get a 7-Day Free Trial

1.43

0.08

Cannabis Global Quarterly Data
	Aug17	Nov17	Feb18	May18	Aug18	Nov18	Feb19	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22
Inventory-to-Revenue	Get a 7-Day Free Trial															0.19	0.29	0.45	0.42	0.25

Competitive Comparison of Cannabis Global's Inventory-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Cannabis Global's Inventory-to-Revenue, along with its competitors' market caps and Inventory-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cannabis Global's Inventory-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cannabis Global's Inventory-to-Revenue distribution charts can be found below:

* The bar in red indicates where Cannabis Global's Inventory-to-Revenue falls into.

Cannabis Global Inventory-to-Revenue Calculation

Cannabis Global's Inventory-to-Revenue for the fiscal year that ended in Aug. 2021 is calculated as

	Inventory-to-Revenue (A: Aug. 2021 )
=	Average Total Inventories					/	Revenue
=	( (Total Inventories (A: Aug. 2020 )	+	Total Inventories (A: Aug. 2021 ))	/	count )	/	Revenue (A: Aug. 2021 )
=	( (0.075	+	0.189)	/	2 )	/	1.601
=	0.132					/	1.601
=	0.08

Cannabis Global's Inventory-to-Revenue for the quarter that ended in May. 2022 is calculated as

	Inventory-to-Revenue (Q: May. 2022 )
=	Average Total Inventories					/	Revenue
=	( (Total Inventories (Q: Feb. 2022 )	+	Total Inventories (Q: May. 2022 ))	/	count )	/	Revenue (Q: May. 2022 )
=	( (0.196	+	0.198)	/	2 )	/	0.792
=	0.197					/	0.792
=	0.25

Cannabis Global (OTCPK:CBGL) Inventory-to-Revenue Explanation

An increase in Inventory-to-Revenue from one quarter to the next indicates that one of the following is happening:

1. investment in inventory is growing more rapidly than revenue
2. revenue are dropping
No matter which situation is causing the problem, an increase in the Inventory-to-Revenue may signal an oncoming cash flow problem.

Likewise, a decrease in the Inventory-to-Revenue from one quarter to next indicates that one of these is occurring:

More Related Terms:

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Cannabis Global's Days Inventory for the three months ended in May. 2022 is calculated as:

Days Inventory	=	Average Total Inventories (Q: May. 2022 )	/	Cost of Goods Sold (Q: May. 2022 )	*	Days in Period
	=	0.197	/	0.78	*	365 / 4
	=	23.05

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Cannabis Global's Inventory Turnover for the quarter that ended in May. 2022 is calculated as

Inventory Turnover	=	Cost of Goods Sold (Q: May. 2022 )	/	Average Total Inventories (Q: May. 2022 )
	=	0.78	/	0.197
	=	3.96

Cannabis Global Inventory-to-Revenue Related Terms

Thank you for viewing the detailed overview of Cannabis Global's Inventory-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Cannabis Global (Cannabis Global) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cannabis Global Inc (OTCPK:CBGL) » Definitions » Inventory-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

520 S. Grand Avenue, Suite 320, Los Angeles, CA, USA, 90071

Website

https://www.cannabisglobalinc.com

Cannabis Global manufactures and distributes various cannabis products via its majority ownership of Natural Plant Extract, Inc is developing the Ethos Comply Bag, and generally conducts research and development in the areas of hemp, cannabis and consumer food goods. The company also have an active research and development program primarily focused on creating and commercializing engineered technologies that deliver hemp extracts and cannabinoids to the human body. Its product includes cannabis flower packaged in various weights, cannabis Pre-rolls, cannabis edible products.

Executives

Jim L. Riley	director	C/O CANNABIS GLOBAL INC., 520 S GRAND AVENUE, SUITE 320, LOS ANGELES CA 90071
Ghs Investments, Llc	10 percent owner	0830 SOUTH EASTERN AVENUE, #124-376, LAS VEGAS NV 89123
Hymers Iii R. Leslie	director, 10 percent owner	520 S GRAND AVENUE, STE 320, LOS ANGELES CA 90071
Arman Tabatabaei	director, officer: CEO, CFO	520 SOUTH GRAND AVENUE, SUITE 320, LOS ANGELES CA 90071
Lauderdale Holdings, Llc	director, 10 percent owner, officer: CEO/President/CFO	1919 NW 19 STREET, FT LAUDERDALE FL 33311
Harmel S Rayat	10 percent owner	700 - 688 WEST HASTINGS STREET, VANCOUVER A1 V6B 1P1
David A Gamache	director, officer: SECRETARY/TREASURER/CFO	3905 NATIONAL DRIVE, SUITE 110, BURTONSVILLE MD 20866
Meetesh V Patel	director, officer: PRESIDENT/CEO	8775 CENTRE PARK DRIVE, # 210, COLUMBIA MD 21045
Pattiann Hiranandani	director	3905 NATIONAL DRIVE, BURTONSVILLE MD 20866